Literature DB >> 7496928

Monoclonal antibodies that distinguish between encephalitogenic bovine herpesvirus type 1.3 and respiratory bovine herpesvirus type 1.1.

C S Chung1, L D Pearson, V K Ayers, J K Collins.   

Abstract

Seven mouse hybridoma cell lines producing monoclonal antibodies (MAb) against an encephalitogenic strain of bovine herpesvirus type 1.3 (BHV-1.3) were established. The clones producing MAb were selected to be specific for BHV-1.3 by enzyme-linked immunosorbent assay. Only L1B neutralized virus without complement. With the addition of complement, five of the MAb neutralized BHV-1.3 but not the respiratory strain BHV-1.1. The anti-BHV-1.3-specific MAb Q10B, L6G, and L1B precipitated glycoproteins from BHV-1.3 that were analogous to the gI, GIII, and gIV glycoproteins of BHV-1.1, respectively. The other four MAb precipitated unknown proteins. None of the anti-BHV-1.3 MAb precipitated BHV-1.1 glycoproteins. The majority of the anti-BHV-1.3 MAb did not react with BHV-1.1 by immunoblotting, but O7E (unknown protein pattern by radioimmunoprecipitation) was reactive with five proteins (M(r)s of 33,000, 43,000, 70,000, 141,000, and 190,000) of BHV-1.3 and with a different pattern of proteins of BHV-1.1 (M(r)s of 30,000, 38,000, 83,000 and 144,000). Two of the MAb, L6G and O7E, conjugated with peroxidase were found to be useful for detecting BHV-1.3 antigen by immunochemistry in Formalin-fixed brain tissue from experimentally infected calves.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496928      PMCID: PMC368201          DOI: 10.1128/cdli.1.1.83-88.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  35 in total

1.  KERATOCONJUCTIVITIS ASSOCIATED WITH INFECTIOUS BOVINE RHINOTRACHEITIS.

Authors:  J P HUGHES; H J OLANDER; M WADA
Journal:  J Am Vet Med Assoc       Date:  1964-07-01       Impact factor: 1.936

2.  Bovine respiratory viruses.

Authors:  S B Mohanty
Journal:  Adv Vet Sci Comp Med       Date:  1978

3.  Bovine encephalitis herpesvirus.

Authors:  M J Studdert
Journal:  Vet Rec       Date:  1989-12-02       Impact factor: 2.695

4.  Immune response to bovine herpes herpesvirus type 1 infections: virus-specific antibodies in sera from infected animals.

Authors:  J K Collins; A C Butcher; C A Riegel
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

5.  Isolation and characterization of a strain of infectious bovine rhinotracheitis virus associated with enteritis in cattle: isolation, serologic characterization, and induction of the experimental disease.

Authors:  J B Gratzek; C P Peter; F K Ramsey
Journal:  Am J Vet Res       Date:  1966-11       Impact factor: 1.156

6.  Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1.

Authors:  J K Collins; A C Butcher; C A Riegel; V McGrane; C D Blair; Y A Teramoto; S Winston
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Herpesvirus-induced "early" glycoprotein: characterization and possible role in immune cytolysis.

Authors:  V Misra; J E Gilchrist; G Weinmaster; L Qualtiere; S Van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

8.  Reactivity of monoclonal antibodies to proteins of a neurotropic bovine herpesvirus 1 (BHV-1) strain and to proteins of representative BHV-1 strains.

Authors:  K Friedli; A E Metzler
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  The genome of bovine herpesvirus 1 (BHV-1) strains exhibiting a neuropathogenic potential compared to known BHV-1 strains by restriction site mapping and cross-hybridization.

Authors:  M Engels; C Giuliani; P Wild; T M Beck; E Loepfe; R Wyler
Journal:  Virus Res       Date:  1986-10       Impact factor: 3.303

10.  Characterization of envelope proteins of infectious bovine rhinotracheitis virus (bovine herpesvirus 1) by biochemical and immunological methods.

Authors:  R L Marshall; L L Rodriguez; G J Letchworth
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.